Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « order »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
orange < order < orders  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000027 (2020) Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
000028 (2020) [Response plan in the neonatal intensive care unit during epidemic of SARS-CoV-2 infection (2nd Edition)].
000043 (2020) Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association [République populaire de Chine] ; Hong Jiang ; Beisha Tang[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].
000045 (2020) Zheng Chen [République populaire de Chine] ; Li-Zhong Du ; Jun-Fen Fu ; Qiang Shu ; Zhi-Min Chen ; Li-Ping Shi ; Wei Wang ; Shuo-Hui Chen ; Xiao-Lu Ma ; Sheng Ye ; Wei Sun ; Ming-Yan Chen ; Hai-Hong Zhu ; Guo-Lan Huang ; Fei-Xiang Luo[Emergency plan for inter-hospital transfer of newborns with SARS-CoV-2 infection].
000095 (2020) Mingxiang Ye [République populaire de Chine] ; Dian Fu [République populaire de Chine] ; Yi Ren [République populaire de Chine] ; Faxiang Wang [République populaire de Chine] ; Dong Wang [République populaire de Chine] ; Fang Zhang [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Tangfeng Lv [République populaire de Chine]Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
000113 (2020) C. Gardiner [Canada] ; J. Veall [Canada] ; S. Lockhart [Canada]The use of UV fluorescent powder for COVID-19 airway management simulation training.
000116 (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
000149 (2020) Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine]The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.
000180 (2020) Jean Christophe Lagier [France] ; Philippe Colson [France] ; Hervé Tissot Dupont [France] ; Jérôme Salomon [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Frédérique Gouriet [France] ; Sophie Baron [France] ; Pierre Dudouet [France] ; Rémi Flores [France] ; Lucie Ailhaud [France] ; Philippe Gautret [France] ; Philippe Parola [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Philippe Brouqui [France]Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
000181 (2020) R. Heij [Royaume-Uni] ; A G Steel [Royaume-Uni] ; P J Young [Royaume-Uni]Testing for coverage from personal protective equipment: Public Health England's guidance does not protect healthcare workers from droplet spray.
000192 (2020) Jose Mose Balibrea [Espagne] ; Josep Mose Badia [Espagne] ; Inés Rubio Pérez [Espagne] ; Esteban Martín Antona [Espagne] ; Estíbaliz Álvarez Pe A [Espagne] ; Sandra García Botella [Espagne] ; Mario Álvarez Gallego [Espagne] ; Elena Martín Pérez [Espagne] ; Sagrario Martínez Cortijo [Espagne] ; Isabel Pascual Miguela Ez [Espagne] ; Lola Pérez Díaz [Espagne] ; Jose Luis Ramos Rodriguez [Espagne] ; Eloy Espin Basany [Espagne] ; Raquel Sánchez Santos [Espagne] ; Victoriano Soria Aledo [Espagne] ; Ruth L Pez Barrachina [Espagne] ; Salvador Morales-Conde [Espagne]Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons.
000228 (2020) Ambra Di Altobrando [Italie] ; Annalisa Patrizi [Italie] ; Federico Bardazzi [Italie]Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
000229 (2020) Daniel P. Sulmasy ; Robert M. VeatchShould Institutions Disclose the Names of Employees with Covid-19?
000251 (2020) Shu-Ren Li [République populaire de Chine] ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li [République populaire de Chine] ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
000302 (2020) H J Wang [République populaire de Chine] ; S H Du [République populaire de Chine] ; X. Yue [République populaire de Chine] ; C X Chen [République populaire de Chine]Review and Prospect of Pathological Features of Corona Virus Disease.
000366 (2020) Boris Krichel ; Sven Falke ; Rolf Hilgenfeld ; Lars Redecke ; Charlotte UetrechtProcessing of the SARS-CoV pp1a/ab nsp7–10 region
000398 (2020) David A. Schwartz [États-Unis] ; Ashley L. GrahamPotential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000399 (2020) Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis]Potential Factors Influencing Repeated SARS Outbreaks in China
000414 (2020) Huwen Wang [République populaire de Chine] ; Zezhou Wang [République populaire de Chine] ; Yinqiao Dong [République populaire de Chine] ; Ruijie Chang [République populaire de Chine] ; Chen Xu [République populaire de Chine] ; Xiaoyue Yu [République populaire de Chine] ; Shuxian Zhang [République populaire de Chine] ; Lhakpa Tsamlag [République populaire de Chine] ; Meili Shang [République populaire de Chine] ; Jinyan Huang [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Gang Xu [République populaire de Chine] ; Tian Shen [République populaire de Chine] ; Xinxin Zhang [République populaire de Chine] ; Yong Cai [République populaire de Chine]Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China
000453 (2020) Anja HolmNew paths for sustainable solutions to tackle global and emerging infectious threats
000586 (2020) P. Conti [Italie] ; C E Gallenga [Italie] ; G. Tetè [Italie] ; Al Caraffa [Italie] ; G. Ronconi [Italie] ; A. Younes [Italie] ; E. Toniato [Italie] ; R. Ross [États-Unis] ; S K Kritas [Grèce]How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "order" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "order" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    order
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021